Craft

Definigen

Total Funding

$9.1 M

Definigen Summary

Company Summary

Overview
Definigen is a company that provides functional disease model human cells, including hepatocytes, pancreatic beta cells, and intestinal organoids. It develops OptiDIFF, a platform technology that focuses on induced pluripotent stem cell (iPSC) generation, CRISPR-Cas9 gene editing, iPSC differentiation, and custom disease model development. The company delivers its services across life science, drug discovery, and regenerative medicine sectors.
Type
Private
Status
Active
Founded
2012
HQ
Babraham, GB | view all locations
Website
https://www.definigen.com/
Cybersecurity rating
Sectors

Key People

  • Ben Cons

    Ben Cons, Chairman

    • Marcus Yeo

      Marcus Yeo, Chief Executive Officer

      • Richard Willock

        Richard Willock, Chief Business Officer

        • Ludovic Vallier

          Ludovic Vallier, Chief Scientific Officer

          LocationsView all

          1 location detected

          • Babraham, England HQ

            United Kingdom

            Babraham Research Campus Moneta Building B280

          Footer menu